Tag Archives: UK

GSK Joins UK–South African Effort to Target Non-communicable Diseases

By Casey McDonald. GSK will weigh in on non-communicable diseases (NCDs) in Africa with a £1m contribution and a commitment of internal R&D expertise supporting researchers from South African institutions, the company announced this month.
Posted in Emerging Markets, Global, healthcare | Also tagged , , , | Leave a comment

PPRS Payments Now Worth £150m in the UK

By Leela Barham. A second payment has now been made under the UK’s Pharmaceutical Price Regulation Scheme (PPRS). Adding a further £76m to the £74m for the first quarter of 2014, the payments received by the Department of Health (DH) now total £150m (US$244m).  Payments are a new feature of the long-standing voluntary PPRS. The […]
Posted in Europe, Guest Blog, Op-Ed, pricing, Regulatory | Also tagged , | Leave a comment

Scottish Life Science Sector’s Referendum Concerns

As the ‘Yes-to-Scottish-independence’ vote gathers strength in the run-up to this week’s historic referendum, some the UK’s big business players last week warned of adverse consequences if Scotland breaks away from the United Kingdom. Most controversially, the Royal Bank of Scotland (RBS) declared that a vote for independence would see it forced to relocate its […]
Posted in Biotech, Europe, Global, R&D | Also tagged , , , | Leave a comment

UK’s Controversial Cancer Fund Boosted — But What’s the Long-Term Plan?

By Leela Barham. The English Cancer Drugs Fund (CDF), set up to provide funding for those products that the National Institute for Health and Care Excellence (NICE) has not recommended for use or where their guidance isn’t yet available, remains controversial. Initially penciled for closure in 2014, it is now planned to run to 2016. […]
Posted in Europe, Guest Blog, Op-Ed, pricing | Also tagged , , , , , | Leave a comment

Pharma & Biotech Most Active Sector in UK M&As

The pharma, medical and biotech (PMB) sector, driven by the Novartis’s £8.6bn acquisition of GlaxoSmithKline’s oncology division, was the most active industry in UK M&A in H1 2014, with a 26.9% market share (£10.1bn), according to Mergermarket’s latest deal round-up. However M&A activity targeting the United Kingdom — standing at £37.5bn in H1 2014 — represented […]
Posted in Deals, Europe | Also tagged , , , | Leave a comment
  • Categories

  • Meta